Roche's PCR test that checks a bowel cancer for common KRAS mutations; a no-mutation result is what the FDA links to cetuximab or panitumumab.
Roche Molecular Systems' cobas KRAS Mutation Test was approved on 7 May 2015 (PMA P140023). The FDA approval statement describes a real-time PCR test, run with the cobas 4800 System, for seven somatic mutations in codons 12 and 13 of KRAS in colorectal cancer tissue, intended as an aid in identifying patients for whom cetuximab or panitumumab may be indicated based on a no mutation detected result. The FDA companion diagnostic list carries it for both drugs. It reads KRAS codons 12 and 13 only; some tests the list carries for panitumumab, such as the CRCDx RAS kit, also read NRAS and further KRAS exons.
Real-time PCR on the cobas 4800 System that detects seven somatic mutations in codons 12 and 13 of the KRAS gene in DNA from formalin-fixed, paraffin-embedded colorectal tumour tissue. Connects to KRAS.
| Where | Who pays | Help with the cost | |
|---|---|---|---|
| 🇺🇸 United States | Approved 2015 | - | - |
Approval is the regulator's decision for any cancer indication, with the year of the first; it is not a promise that a hospital stocks the drug or that your indication is covered. Not recorded for European Union, United Kingdom, Japan, China, Australia, India: a gap in our research, not a refusal. Compare products across regions.
| Region | Year | Indication |
|---|---|---|
| US | 2015 | KRAS codon 12 and 13 no mutation detected, as an aid in selecting cetuximab or panitumumab in colorectal cancer |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"cobas KRAS Mutation Test" OR ABSTRACT:"cobas KRAS Mutation Test" OR TITLE:"Roche cobas KRAS Mutation Test" OR ABSTRACT:"Roche cobas KRAS Mutation Test") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about cobas KRAS Mutation Test, not a curated reading list.
Shares Panitumumab, Companion diagnostic, Companion diagnostics, Cetuximab and the tag test.
Shares Companion diagnostic, Pathologic complete response (pCR), Companion diagnostics, Roche / Genentech and the tag test.
Shares Companion diagnostic, Pathologic complete response (pCR), Companion diagnostics, Roche / Genentech and the tag test.
Shares Companion diagnostic, Companion diagnostics, Roche / Genentech and the tag test.
Shares Companion diagnostic, Companion diagnostics, Roche / Genentech and the tag test.
Shares Companion diagnostic, Companion diagnostics, Roche / Genentech and the tag test.
Shares Companion diagnostic, Companion diagnostics, Roche / Genentech and the tag test.
Shares Companion diagnostic, Pathologic complete response (pCR), Companion diagnostics and the tag test.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/